Literature DB >> 7637040

In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation.

O Billet1, G Grimber, M Levrero, K A Seye, P Briand, V Joulin.   

Abstract

The contribution of the hepatitis B virus enhancers I and II in the regulation of the activity of the core and the X promoters was assessed in transgenic mice. Surprisingly, despite the presence of heterologous promoters linked 5' of the X gene, the transgene expression is mostly due to core promoter (Cp) activity present in the X coding sequence. Moreover, the restriction of Cp activity to hepatic tissue required the combined action of both enhancers I and II, whereas the proximity of these two enhancers was insufficient to confer tissue specificity on Xp activity. Furthermore, the liver-specific activity of the Cp was developmentally regulated in an enhancer I-independent manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637040      PMCID: PMC189474     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  A liver-specific enhancer in the core promoter region of human hepatitis B virus.

Authors:  J K Yee
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

Authors:  J Honigwachs; O Faktor; R Dikstein; Y Shaul; O Laub
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Cellular factors that interact with the hepatitis B virus enhancer.

Authors:  R Ben-Levy; O Faktor; I Berger; Y Shaul
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

4.  Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity.

Authors:  J L Vannice; A D Levinson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

5.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity.

Authors:  S Jameel; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

7.  Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner.

Authors:  T K Antonucci; W J Rutter
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Hepatitis B virus X gene product acts as a transactivator in vivo.

Authors:  C Balsano; O Billet; M Bennoun; C Cavard; A Zider; G Grimber; G Natoli; P Briand; M Levrero
Journal:  J Hepatol       Date:  1994-07       Impact factor: 25.083

9.  A human hepatitis B viral enhancer element.

Authors:  Y Shaul; W J Rutter; O Laub
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

10.  Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences.

Authors:  Y Shaul; R Ben-Levy
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  14 in total

1.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx.

Authors:  Tianyu Jiang; Minhao Liu; Jianping Wu; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

3.  Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection.

Authors:  Jong-Han Lee; Kwang-Hyub Han; Jae Myun Lee; Jeon Han Park; Hyon-Suk Kim
Journal:  Clin Vaccine Immunol       Date:  2011-04-13

4.  Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  The hepatitis B virus X protein transactivates viral core gene expression in vivo.

Authors:  K Reifenberg; H Wilts; J Löhler; P Nusser; R Hanano; L G Guidotti; F V Chisari; H J Schlicht
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 7.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

8.  Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene.

Authors:  Huan-Zhang Zhu; Guo-Xiang Cheng; Jian-Qu Chen; Shu-Yuan Kuang; Yong Cheng; Xin-Li Zhang; Hou-Da Li; Shao-Fu Xu; Jing-Quan Shi; Geng-Sun Qian; Jian-Ren Gu
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

9.  Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis.

Authors:  J Guilherme Tralhao; Jean Roudier; Serban Morosan; Carlo Giannini; Hong Tu; Cyril Goulenok; Françoise Carnot; Flora Zavala; Virginie Joulin; Dina Kremsdorf; Christian Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 10.  Hepatitis B Virus X and Regulation of Viral Gene Expression.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.